RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Clinical trial NCT01193881 · TERMINATED

Trial details

NCT number: NCT01193881
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer

Start date: 2010-08-01
Primary completion: 2015-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.